This page includes the latest FDA filings for Oticon Medical2720 Chemin Saint Bernardvallauris 06220 Pma Numberp200021 Supplement Numbers012 Date Received04 29 2022 Decision Date05 27 2022 Product Code Mcm Advisory Committee Ear Nose Throat Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Oticon Medical2720 Chemin Saint Bernardvallauris 06220 PMA NumberP200021 Supplement NumberS012 Date Received04/29/2022 Decision Date05/27/2022 Product Code MCM Advisory Committee Ear Nose & Throat Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | Neuro Cochlear Implant System (NCIS) | 2022-05-27 |